Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAP Study: IGIV for Alzheimer's Disease
NCT00818662Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2008
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in Alzheimer's disease (AD), sponsored by Takeda. Started Dec 2008; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00818662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818662.